Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
10/16/1997 | CA2250268A1 Extracellular/epidermal growth factor hcaba58x |
10/16/1997 | CA2249298A1 In vitro assay for identification of carcinogens |
10/16/1997 | CA2249213A1 Extracellular/epidermal growth factor-like protein |
10/16/1997 | CA2222813A1 Variant presenilin-2 genes |
10/15/1997 | EP0801307A2 Compositions and methods for screening drug libraries |
10/15/1997 | EP0801132A2 Staphylococcal FtsH protein |
10/15/1997 | EP0801076A1 Thrombocytotic factor |
10/15/1997 | EP0801074A1 Isolation of peptides from green barley leaf extract and use of same to inhibit human platelet aggregation |
10/15/1997 | EP0800862A1 Adsorbent for endotoxin, tumor necrosis factor-alpha or interleukins, method for removal via adsorption, and adsorber |
10/15/1997 | EP0800649A1 Inhibition of glial cell proliferation |
10/15/1997 | EP0800588A1 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support |
10/15/1997 | EP0800585A1 Hydroxyproline-rich proteins and pharmaceutical and cosmetic formulations containing them |
10/15/1997 | EP0800582A1 Transgenic plants expressing dna constructs containing a plurality of genes to impart virus resistance |
10/15/1997 | EP0800579A2 Combination gene delivery vehicles |
10/15/1997 | EP0800578A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
10/15/1997 | EP0800577A1 Recombinant dna molecules and expression vectors for erythropoietin |
10/15/1997 | EP0800576A1 Expression system, vector and cell transformed thereby |
10/15/1997 | EP0800536A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
10/15/1997 | EP0800535A1 Fibronectin adhesion inhibitors |
10/15/1997 | EP0800534A2 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases |
10/15/1997 | EP0800533A1 Anti-inflammatory cd14 peptides |
10/15/1997 | EP0800532A1 Improved cyclic crf agonists |
10/15/1997 | EP0800531A2 Novel receptor tyrosine kinases |
10/15/1997 | EP0800530A1 Igf/igfbp complex for promoting bone formation and for regulating bone remodeling |
10/15/1997 | EP0800405A1 Continuous low-dose administration of parathyroid hormone or its agonist |
10/15/1997 | EP0800403A2 Non-traumatic administration of gene delivery vehicles |
10/15/1997 | EP0688364A4 Genetically engineered enzymes and their conjugates for diagnostic assays |
10/15/1997 | EP0673392A4 Method of preferential labelling of phycobiliprotein with amine-reactive dye for use in a multiple color assay. |
10/15/1997 | EP0646013A4 Platelet derived growth factor antagonists. |
10/15/1997 | EP0620851B1 Neuroblastoma-associated regulator gene |
10/15/1997 | EP0555439B1 Streptolysin o derivatives |
10/15/1997 | EP0544781B1 New peptides and their use |
10/15/1997 | EP0511964B1 METHOD FOR PREPARING A PROTEIN SELECTED FROM THE CYTOKINE GROUP, COMPRISING AT LEAST ONE INTRAMOLECULAR DISULPHIDE BOND BY OXIDATION, AT A pH OF LESS THAN 5.0, OF THE REDUCED RECOMBINANT PROTEIN |
10/15/1997 | EP0460178B1 Cd4 specific recombinant antibody |
10/15/1997 | EP0377582B1 Lipid microemulsions for culture media |
10/15/1997 | EP0294469B1 Vaccines and diagnostic assays for haemophilus influenzae |
10/15/1997 | EP0179075B2 Virus risk-reduced hemoglobin and method for making same |
10/15/1997 | CN1162338A Viable contaminant particle free adenoviruses, their preparation and use |
10/15/1997 | CN1162336A Identification of human cytomegalovirus gene region involved in down-regulation of MHC class I heavy chain expression |
10/15/1997 | CN1162335A Modified human C3 proteins |
10/15/1997 | CN1162318A New peptide active substance and production thereof |
10/15/1997 | CN1162267A Methods and compositions for specific coagulation of vasculature |
10/15/1997 | CN1162266A Novel brain endothelial cell protein and methods for its use |
10/15/1997 | CN1161973A Two-step purifying method for plasminogen activator of recombined humanbody tissue type |
10/14/1997 | US5677438 Polynucletide sequence |
10/14/1997 | US5677430 Hodgkin*s disease |
10/14/1997 | US5677428 Mono- or polyclonal antibody raised against human double-stranded rna adenosine deaminase |
10/14/1997 | US5677424 Chromatography |
10/14/1997 | US5677421 Target proteins for eukaryotic tyrosine kinases |
10/14/1997 | US5677419 Cyclic vasoactive peptide analogs |
10/14/1997 | US5677284 Charged collagen particle-based delivery matrix |
10/14/1997 | US5677280 Peptides and compounds that bind to the IL-5 receptor |
10/14/1997 | US5677278 Truncated keratinocyte growth factor (KGF) having increased biological activity |
10/14/1997 | US5677277 Brain disorders |
10/14/1997 | US5677276 Wound healing and tissue regeneration |
10/14/1997 | US5677274 Anthrax toxin fusion proteins and related methods |
10/14/1997 | US5677198 Assay for peptide metabolites from the amino-terminal telopeptide domain of type I collagen |
10/14/1997 | US5677195 Forming oligonucleotides or peptides by forming flow channels in substrate surface, each of flow channels comprising walls which form fluid-tight seals with surface and a flow intake and outlet, flowing nucleic acids through channels to bind |
10/14/1997 | US5677184 Genetic engineered chinese hamster ovary cells |
10/14/1997 | US5677182 Cleavage site blocking antibody to prohormone proteins and uses thereof |
10/14/1997 | US5677180 Chimeric antibody with specificity to human B cell surface antigen |
10/14/1997 | US5677179 Respiratory system disorder |
10/14/1997 | US5677175 Plant pathogen induced proteins |
10/14/1997 | US5677172 Method for production of proteins in yeast |
10/14/1997 | US5677171 Inhibit growth of sk-br-3 breast tumor cells |
10/14/1997 | US5677165 Anti-CD40 monoclonal antibodies capable of blocking B-cell activation |
10/14/1997 | US5677164 Hepatocyte growth factor activating protease and gene encoding the protease |
10/14/1997 | US5677159 Genomic DNA of human cholesterol 7α-hydroxylase and methods for using it |
10/14/1997 | US5677149 Culturing under suitable conditions a host cell transformed or trasnfected with a replicable vector comprising specific nucleic acid sequence in a manner allowing expression of the polypeptide and recovering transformed polypeptide |
10/14/1997 | US5677148 Genetic engineering |
10/14/1997 | US5677147 HIV-2 virus variants |
10/14/1997 | US5677146 Human amyloid protein precursor homolog and kunitz-type inhibitor |
10/14/1997 | US5677144 Genetic engineered vectors expressing a polypeptide |
10/14/1997 | US5677143 Isolated nucleic acid encoding amino acid sequence of cellular protein |
10/14/1997 | US5677131 System to detect protein-RNA interactions |
10/14/1997 | US5677130 BCL-1 locus nucleic acid probes and assay methods |
10/14/1997 | US5677125 Method of detection and diagnosis of pre-invasive cancer |
10/14/1997 | US5677124 Nucleic acid encapsulated by bacteriophage protein |
10/14/1997 | US5676978 Methods of inhibiting undesirable cell growth using a combination of a cyclocreatine compound and a hyperplastic inhibitory agent |
10/14/1997 | US5676953 Intestinal protozoal vaccines |
10/14/1997 | US5676952 Genetic engineered vaccine |
10/14/1997 | US5676951 Bovine herpesvirus type 1 deletion mutants and vaccines |
10/14/1997 | US5676943 Nerve growth factor |
10/14/1997 | US5676942 Composition containing human alpha interferon species proteins and method for use thereof |
10/14/1997 | US5676941 Methods of enhancing bone marrow transplantation and treating burn wounds comprising administering human pluripotent granulocyte colony-stimulating factor |
10/14/1997 | CA1339495C A process for producing human growth hormone |
10/13/1997 | CA2178132A1 Isolation of novel peptides from green barley leaf extract and use of same to inhibit human platelet aggregation |
10/10/1997 | CA2190812A1 Polypeptide |
10/09/1997 | WO1997037230A1 Tfiib transcription factor from candida albicans |
10/09/1997 | WO1997037228A1 Methods for diagnosing and treating alzheimer's disease |
10/09/1997 | WO1997037225A1 A PROTEIN PREPARATION THAT MEDIATES Ca2+-DEPENDENT TRANSBILAYER MOVEMENT OF PLASMA MEMBRANE PHOSPHOLIPID AND INHIBITORS THEREOF |
10/09/1997 | WO1997037224A1 Protein phosphatase-1 catalytic subunit interactions |
10/09/1997 | WO1997037223A1 Identification and isolation of novel polypeptides having ww domains and methods of using same |
10/09/1997 | WO1997037220A1 Compositions and methods for screening drug libraries |
10/09/1997 | WO1997037044A1 Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof |
10/09/1997 | WO1997037037A1 Phosphatase modulator |
10/09/1997 | WO1997037031A1 Parapoxvirus vectors |
10/09/1997 | WO1997037030A1 Method of screening dna-binding protein, plasmid to be used therefor, and dna-binding protein |
10/09/1997 | WO1997037026A1 Novel compounds |
10/09/1997 | WO1997037025A1 Surface anchoring vector and system for foreign proteins thereof |